Wyeth believes the data from these nearly 1,000 women provide additional support for a favorable benefit to risk ratio for bazedoxifene in the prevention of postmenopausal osteoporosis.

• 惠氏相信，由接近1000名妇女获得的研究数据制作的这2份研究报告，将为苯卓昔芬在预防绝经后骨质疏松症过程中低副作用风险提供有力的支持。